Emmessar Biotech & Nutrition Limited share price
BSE: EMMESSA
Key numbers
- Market cap
- ₹ 11.6 Cr
- Current price
- ₹ 23.16
- 52-week high / low
- ₹ 34 / 18
- Stock P/E
- 29.3
- Book value
- ₹ 12.6
- Dividend yield
- 0.00%
- ROCE
- 7.3%
- ROE
- 5.6%
- Debt to equity
- 0.00
- Sales growth (3 yrs)
- -28.7%
- Profit growth (3 yrs)
- -4.2%
- 1-year return
- -37.5%
About Emmessar Biotech & Nutrition Limited
Emmessar Biotech & Nutrition Limited, a healthcare company, provides healthcare and nutritional products in India and internationally. The company operates through Healthcare and Rent on Lease Land segments. It also offers CalmCream, a multi-functional skin cream; Calm Cream RESQ, a skin cream used for burns from sun, radiation, heat and chemicals; Cute-N-Comely, a cosmetic skin cream; MagiCream, a cream used for post-surgical scars; and Muscle Flex Gel, a gel used to relieve pain from aching muscles. In addition, the company offers vedaceuticals, an ayurveda disease curing medicine. Further, it provides healthcare products for dermatology, Muscular Pains & Functions, osteoporosis, General Health, anti-ageing, cosmatics, and burns, including radiation. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000. Emmessar Biotech & Nutrition Limited was incorporated in 1992 and is based in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 |
| Operating profit | -0 | -0 | -0 | -0 | -0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| EPS (₹) | 0.34 | 0.23 | 0.23 | 0.07 | 0.26 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.